Study
Nir Barzilai, M.D. Named Chief Medical Advisor of Life Biosciences
PRIMARY
2023
Summary Does this appointment prove the company’s longevity treatments work? Show / hide ↓
This is a company announcement, not a research study. A well-known aging researcher was appointed as the company’s chief medical advisor. The role is to provide scientific guidance. No patients, treatments, or health results were reported.
What this means for you: This announcement does not show that any longevity treatment works or is safe. You can ignore it when deciding what to buy or take.
solid evidenceDesignPRIMARY
TierTier 4, Ingredient RCT (different dose)
Year2023
JournalBioSpace
Added to NO1GEVITYJul 9, 2026
Cited by
1 encyclopedia entries reference this study.